4.6 Article

High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes

期刊

出版社

WILEY
DOI: 10.1161/JAHA.117.007914

关键词

atherosclerosis; coronary angiography; coronary artery disease; troponin

资金

  1. Abbott
  2. National Institutes of Health (NIH) [5P01HL101398-02, 1P20HL113451-01, 1R56HL126558-01, 1RF1AG051633-01, R01 NS064162-01, R01 HL89650-01, HL095479-01, 1U10HL110302-01, 1DP3DK094346-01, 2P01HL086773-06A1]
  3. Abraham J. & Phyllis Katz Foundation grant (Atlanta, GA)
  4. NIH/National Institute on Aging grant [AG051633]
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL134290, U10HL110302] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE ON AGING [RF1AG051633] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background-The associations between high-sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value of hsTnI level for incident cardiovascular outcomes is independent of CAD severity. Methods and Results-In 3087 patients (aged 63 +/- 12years, 64% men) undergoing cardiac catheterization without evidence of acute myocardial infarction, the severity of CAD was calculated by the number of major coronary arteries with >= 50% stenosis and the Gensini score. CAD progression was assessed in a subset of 717 patients who had undergone >= 2 coronary angiograms >3months before enrollment. Patients were followed up for incident all-cause mortality and incident cardiovascular events. Of the total population, 11% had normal angiograms, 23% had nonobstructive CAD, 20% had 1-vessel CAD, 20% had 2-vessel CAD, and 26% had 3-vessel CAD. After adjusting for age, sex, race, body mass index, smoking, hypertension, diabetes mellitus history, and renal function, hsTnI levels were independently associated with the severity of CAD measured by the Gensini score (log 2 beta=0.31; 95% confidence interval, 0.18-0.44; P<0.001) and with CAD progression (log 2 beta=0.36; 95% confidence interval, 0.14-0.58; P=0.001). hsTnI level was also a significant predictor of incident death, cardiovascular death, myocardial infarction, revascularization, and cardiac hospitalizations, independent of the aforementioned covariates and CAD severity. Conclusions-Higher hsTnI levels are associated with the underlying burden of coronary atherosclerosis, more rapid progression of CAD, and higher risk of all-cause mortality and incident cardiovascular events. Whether more aggressive treatment aimed at reducing hsTnI levels can modulate disease progression requires further investigation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据